Business Description
Level Bio AB
NAICS : 334517
ISIN : SE0000885501
Compare
Compare
Traded in other countries / regions
LEVBIO.Sweden4MB.Germany IPO Date
2021-05-05Description
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.49 | |||||
| Beneish M-Score | -3.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.5 | |||||
| 3-Year Book Growth Rate | 42.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.54 | |||||
| 9-Day RSI | 48.69 | |||||
| 14-Day RSI | 46.4 | |||||
| 6-1 Month Momentum % | 2.38 | |||||
| 12-1 Month Momentum % | -41.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 120.88 | |||||
| Days Sales Outstanding | 57.25 | |||||
| Days Payable | 46.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.79 | |||||
| Operating Margin % | -42.44 | |||||
| Net Margin % | -45.35 | |||||
| FCF Margin % | -26.76 | |||||
| ROE % | -124.06 | |||||
| ROA % | -62.85 | |||||
| ROIC % | -70.05 | |||||
| ROC (Joel Greenblatt) % | -710.97 | |||||
| ROCE % | -116.91 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.81 | |||||
| PB Ratio | 3.31 | |||||
| EV-to-EBIT | -1.59 | |||||
| EV-to-EBITDA | -1.87 | |||||
| EV-to-Revenue | 0.72 | |||||
| EV-to-FCF | -2.48 | |||||
| Price-to-Median-PS-Value | 0.24 | |||||
| Earnings Yield (Greenblatt) % | -62.99 | |||||
| FCF Yield % | -32.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Bio AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.104 | ||
| EPS (TTM) (€) | -0.015 | ||
| Beta | 0.75 | ||
| Volatility % | 73.99 | ||
| 14-Day RSI | 46.4 | ||
| 14-Day ATR (€) | 0.002524 | ||
| 20-Day SMA (€) | 0.014175 | ||
| 12-1 Month Momentum % | -41.26 | ||
| 52-Week Range (€) | 0.0045 - 0.0352 | ||
| Shares Outstanding (Mil) | 68.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Level Bio AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Level Bio AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Level Bio AB Frequently Asked Questions
What is Level Bio AB(FRA:4MB)'s stock price today?
The current price of FRA:4MB is €0.01. The 52 week high of FRA:4MB is €0.04 and 52 week low is €0.00.
When is next earnings date of Level Bio AB(FRA:4MB)?
The next earnings date of Level Bio AB(FRA:4MB) is 2025-02-21 Est..
Does Level Bio AB(FRA:4MB) pay dividends? If so, how much?
Level Bio AB(FRA:4MB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers